Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-12-15
1991-10-15
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 18, 514300, 530330, 530331, 546123, 546156, C07D215233
Patent
active
050575236
ABSTRACT:
7-(3-A-amino-1-pyrrolidinyl) substituted naphthyridine and quinoline compounds wherein A is a solubilizing group selected from an amino acid residue or polypeptide chain.
REFERENCES:
patent: 4479898 (1984-10-01), Gilvarg
patent: 4616019 (1986-10-01), Chu
patent: 4621088 (1986-11-01), Laruelle et al.
patent: 4649144 (1987-03-01), Matsumoto et al.
patent: 4730000 (1988-03-01), Chu
patent: 4735949 (1988-04-01), Domagala et al.
patent: 4753984 (1988-06-01), Delmotte
patent: 4851418 (1989-07-01), Sanchez
patent: 4859776 (1989-08-01), Chu et al.
patent: 4886810 (1989-12-01), Matsumoto
patent: 4916141 (1990-04-01), Sanchez
patent: 4920120 (1990-04-01), Domagala et al.
patent: 4992449 (1991-02-01), Bitha et al.
Egawa et al., J. Med. Chem. 27, No. 12, pp. 543-548 (1984).
Chu Daniel T.
Hallas Robert
Abbott Laboratories
Danckers Andreas M.
Daus Donald G.
Janssen Jerry F.
LandOfFree
Dipeptide quinolone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dipeptide quinolone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipeptide quinolone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-991492